TY - JOUR
T1 - MicroRNA-146a induces lineage-negative bone marrow cell apoptosis and senescence by targeting polo-like kinase 2 expression
AU - Deng, Shanming
AU - Wang, Huilan
AU - Jia, Chunling
AU - Zhu, Shoukang
AU - Chu, Xianming
AU - Ma, Qi
AU - Wei, Jianqin
AU - Chen, Emily
AU - Zhu, Wei
AU - Macon, Conrad J.
AU - Jayaweera, Dushyantha T.
AU - Dykxhoorn, Derek M.
AU - Dong, Chunming
N1 - Funding Information:
This work was supported by a grant from National Institutes of Health (AG041754) and a grant from the Florida Biomedical Research Program (4KB06) to Dr Dong.
Publisher Copyright:
© 2016 American Heart Association, Inc.
PY - 2017/2/1
Y1 - 2017/2/1
N2 - Objective - Lineage-negative bone marrow cells (lin- BMCs) are enriched in endothelial progenitor cells and mediate vascular repair. Aging-associated senescence and apoptosis result in reduced number and functionality of lin- BMCs, impairing their prorepair capacity. The molecular mechanisms underlying lin- BMC senescence and apoptosis are poorly understood. MicroRNAs (miRNAs) regulate many important biological processes. The identification of miRNA-mRNA networks that modulate the health and functionality of lin- BMCs is a critical step in understanding the process of vascular repair. The aim of this study was to characterize the role of the miR-146a-Polo-like kinase 2 (Plk2) network in regulating lin- BMC senescence, apoptosis, and their angiogenic capability. Approach and Results - Transcriptome analysis in lin- BMCs isolated from young and aged wild-type and ApoE -/- (apolipoprotein E) mice showed a significant age-associated increase in miR-146a expression. In silico analysis, expression study and Luciferase reporter assay established Plk2 as a direct target of miR-146a. miR-146a overexpression in young lin- BMCs inhibited Plk2 expression, resulting in increased senescence and apoptosis, via p16Ink4a/p19Arf and p53, respectively, as well as impaired angiogenic capacity in vitro and in vivo. Conversely, suppression of miR-146a in aged lin- BMCs increased Plk2 expression and rejuvenated lin- BMCs, resulting in decreased senescence and apoptosis, leading to improved angiogenesis. Conclusions - (1) miR-146a regulates lin- BMC senescence and apoptosis by suppressing Plk2 expression that, in turn, activates p16Ink4a/p19Arf and p53 and (2) modulation of miR-146a or its target Plk2 may represent a potential therapeutic intervention to improve lin- BMC-mediated angiogenesis and vascular repair.
AB - Objective - Lineage-negative bone marrow cells (lin- BMCs) are enriched in endothelial progenitor cells and mediate vascular repair. Aging-associated senescence and apoptosis result in reduced number and functionality of lin- BMCs, impairing their prorepair capacity. The molecular mechanisms underlying lin- BMC senescence and apoptosis are poorly understood. MicroRNAs (miRNAs) regulate many important biological processes. The identification of miRNA-mRNA networks that modulate the health and functionality of lin- BMCs is a critical step in understanding the process of vascular repair. The aim of this study was to characterize the role of the miR-146a-Polo-like kinase 2 (Plk2) network in regulating lin- BMC senescence, apoptosis, and their angiogenic capability. Approach and Results - Transcriptome analysis in lin- BMCs isolated from young and aged wild-type and ApoE -/- (apolipoprotein E) mice showed a significant age-associated increase in miR-146a expression. In silico analysis, expression study and Luciferase reporter assay established Plk2 as a direct target of miR-146a. miR-146a overexpression in young lin- BMCs inhibited Plk2 expression, resulting in increased senescence and apoptosis, via p16Ink4a/p19Arf and p53, respectively, as well as impaired angiogenic capacity in vitro and in vivo. Conversely, suppression of miR-146a in aged lin- BMCs increased Plk2 expression and rejuvenated lin- BMCs, resulting in decreased senescence and apoptosis, leading to improved angiogenesis. Conclusions - (1) miR-146a regulates lin- BMC senescence and apoptosis by suppressing Plk2 expression that, in turn, activates p16Ink4a/p19Arf and p53 and (2) modulation of miR-146a or its target Plk2 may represent a potential therapeutic intervention to improve lin- BMC-mediated angiogenesis and vascular repair.
KW - apoptosis
KW - cardiovascular diseases
KW - mice
KW - microRNAs
KW - progenitor cells
UR - http://www.scopus.com/inward/record.url?scp=85002235393&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85002235393&partnerID=8YFLogxK
U2 - 10.1161/ATVBAHA.116.308378
DO - 10.1161/ATVBAHA.116.308378
M3 - Article
C2 - 27908889
AN - SCOPUS:85002235393
SN - 1079-5642
VL - 37
SP - 280
EP - 290
JO - Arteriosclerosis, Thrombosis, and Vascular Biology
JF - Arteriosclerosis, Thrombosis, and Vascular Biology
IS - 2
ER -